{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:23:08Z","timestamp":1793330588817,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0203B"],"award-info":[{"award-number":["031L0203B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0203B"],"award-info":[{"award-number":["031L0203B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0203C"],"award-info":[{"award-number":["031L0203C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0203C"],"award-info":[{"award-number":["031L0203C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0203A"],"award-info":[{"award-number":["031L0203A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031L0203A"],"award-info":[{"award-number":["031L0203A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EVUK programme"},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rare oncogenic driver events, particularly affecting the expression or splicing of driver genes, are suspected to substantially contribute to the large heterogeneity of hematologic malignancies. However, their identification remains challenging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To address this issue, we generated the largest dataset to date of matched whole genome sequencing and total RNA sequencing of hematologic malignancies from 3760 patients spanning 24 disease entities. Taking advantage of our dataset size, we focused on discovering rare regulatory aberrations. Therefore, we called expression and splicing outliers using an extension of the workflow DROP (Detection of RNA Outliers Pipeline) and AbSplice, a variant effect predictor that identifies genetic variants causing aberrant splicing. We next trained a machine learning model integrating these results to prioritize new candidate disease-specific driver genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found a median of seven expression outlier genes, two splicing outlier genes, and two rare splice-affecting variants per sample. Each category showed significant enrichment for already well-characterized driver genes, with odds ratios exceeding three among genes called in more than five samples. On held-out data, our integrative modeling significantly outperformed modeling based solely on genomic data and revealed promising novel candidate driver genes. Remarkably, we found a truncated form of the low density lipoprotein receptor <jats:italic>LRP1B<\/jats:italic> transcript to be aberrantly overexpressed in about half of hairy cell leukemia variant (HCL-V) samples and, to a lesser extent, in closely related B-cell neoplasms. This observation, which was confirmed in an independent cohort, suggests <jats:italic>LRP1B<\/jats:italic> as a novel marker for a HCL-V subclass and a yet unreported functional role of <jats:italic>LRP1B<\/jats:italic> within these rare entities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Altogether, our census of expression and splicing outliers for 24 hematologic malignancy entities and the companion computational workflow constitute unique resources to deepen our understanding of rare oncogenic events in hematologic cancers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13073-024-01331-6","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T11:02:07Z","timestamp":1716202927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9019-0403","authenticated-orcid":false,"given":"Xueqi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata Jadid","family":"Ahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-1941","authenticated-orcid":false,"given":"Franziska R.","family":"Traube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Secheyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-1356","authenticated-orcid":false,"given":"Sergey","family":"Vilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4533-7857","authenticated-orcid":false,"given":"Ines F.","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-3643","authenticated-orcid":false,"given":"Vicente A.","family":"Y\u00e9pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers","family":"Blombery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-1720","authenticated-orcid":false,"given":"Matthias","family":"Heinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-040X","authenticated-orcid":false,"given":"Leonhard","family":"Wachutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8924-8365","authenticated-orcid":false,"given":"Julien","family":"Gagneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"issue":"3","key":"1331_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"1331_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia."},{"issue":"5","key":"1331_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s43018-023-00550-x","volume":"4","author":"SR de Matos","year":"2023","unstructured":"de Matos SR, Shirasaki R, Downey-Kopyscinski SL, Matthews GM, Barwick BG, Gupta VA, et al. Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nat Cancer. 2023;4(5):754\u201373.","journal-title":"Nat Cancer"},{"issue":"10","key":"1331_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1182\/blood.2021012734","volume":"139","author":"T Ishio","year":"2022","unstructured":"Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin Y, et al. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia\/lymphoma. Blood. 2022;139(10):1541\u201356.","journal-title":"Blood"},{"issue":"1","key":"1331_CR5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41467-019-09180-3","volume":"10","author":"J Weber","year":"2019","unstructured":"Weber J, de la Rosa J, Grove CS, Schick M, Rad L, Baranov O, et al. PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice. Nat Commun. 2019;10(1):1415.","journal-title":"Nat Commun"},{"issue":"3","key":"1331_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3324\/haematol.2019.242677","volume":"106","author":"S Vantyghem","year":"2021","unstructured":"Vantyghem S, Peterlin P, Th\u00e9pot S, M\u00e9nard A, Dubruille V, Debord C, et al. Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study. Haematologica. 2021;106(3):701\u201307.","journal-title":"Haematologica"},{"issue":"11","key":"1331_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.humimm.2021.02.006","volume":"82","author":"LA Ramkissoon","year":"2021","unstructured":"Ramkissoon LA, Montgomery ND. Applications of next-generation sequencing in hematologic malignancies. Hum Immunol. 2021;82(11):859\u201370.","journal-title":"Hum Immunol"},{"issue":"7","key":"1331_CR8","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"11","key":"1331_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"issue":"11","key":"1331_CR10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140(11):1229\u201353.","journal-title":"Blood"},{"issue":"7","key":"1331_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molmed.2023.03.007","volume":"29","author":"D Ostroverkhova","year":"2023","unstructured":"Ostroverkhova D, Przytycka TM, Panchenko AR. Cancer driver mutations: predictions and reality. Trends Mol Med. 2023;29(7):554\u201366.","journal-title":"Trends Mol Med"},{"issue":"12","key":"1331_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.tips.2019.10.003","volume":"40","author":"R Nussinov","year":"2019","unstructured":"Nussinov R, Tsai CJ, Jang H. Why are some driver mutations rare? Trends Pharmacol Sci. 2019;40(12):919\u201329.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1331_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-022-00342-z","volume":"7","author":"M Esai Selvan","year":"2023","unstructured":"Esai Selvan M, Onel K, Gnjatic S, Klein RJ, G\u00fcm\u00fc\u015f ZH. Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics. Npj Precis Oncol. 2023;7(1):1\u201312.","journal-title":"Npj Precis Oncol"},{"key":"1331_CR14","doi-asserted-by":"publisher","unstructured":"Kuan-lin Huang, R. Jay Mash, Yige Wu et al. Cell. 173;(2)355\u201370.e14. https:\/\/doi.org\/10.1016\/j.cell.2018.03.039.","DOI":"10.1016\/j.cell.2018.03.039"},{"issue":"1","key":"1331_CR15","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1038\/ncomms4156","volume":"5","author":"KL Kanchi","year":"2014","unstructured":"Kanchi KL, Johnson KJ, Lu C, McLellan MD, Leiserson MDM, Wendl MC, et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun. 2014;5(1):3156.","journal-title":"Nat Commun"},{"issue":"1","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1038\/ncomms10086","volume":"6","author":"C Lu","year":"2015","unstructured":"Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MDM, et al. Patterns and functional implications of rare germline variants across 12 cancer types. Nat Commun. 2015;6(1):10086.","journal-title":"Nat Commun"},{"issue":"6","key":"1331_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/cancers13061340","volume":"13","author":"A Mosquera Orgueira","year":"2021","unstructured":"Orgueira AM, L\u00f3pez CM, Ra\u00edndo PA, Arias J\u00c1D, Rodr\u00edguez AB, P\u00e9rez LB, et al. Detection of rare germline variants in the genomes of patients with B-cell neoplasms. Cancers. 2021;13(6):1340.","journal-title":"Cancers"},{"issue":"1","key":"1331_CR18","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1038\/s41467-022-31483-1","volume":"13","author":"M Vali-Pour","year":"2022","unstructured":"Vali-Pour M, Park S, Espinosa-Carrasco J, Ortiz-Mart\u00ednez D, Lehner B, Supek F. The impact of rare germline variants on human somatic mutation processes. Nat Commun. 2022;13(1):3724.","journal-title":"Nat Commun"},{"issue":"7793","key":"1331_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41586-020-1970-0","volume":"578","author":"C Calabrese","year":"2020","unstructured":"Calabrese C, Davidson NR, Demircio\u011flu D, Fonseca NA, He Y, Kahles A, et al. Genomic basis for RNA alterations in cancer. Nature. 2020;578(7793):129\u201336.","journal-title":"Nature"},{"issue":"8","key":"1331_CR20","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3390\/cancers12082216","volume":"12","author":"M Hautin","year":"2020","unstructured":"Hautin M, Mornet C, Chauveau A, Bernard D, Corcos L, Lippert E. Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues. Cancers. 2020;12(8):2216.","journal-title":"Cancers"},{"issue":"1","key":"1331_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41467-020-20848-z","volume":"12","author":"VV Grinev","year":"2021","unstructured":"Grinev VV, Barneh F, Ilyushonak IM, Nakjang S, Smink J, Van Oort A, et al. RUNX1\/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia. Nat Commun. 2021;12(1):520.","journal-title":"Nat Commun"},{"issue":"8","key":"1331_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1182\/blood.2021015325","volume":"140","author":"A Tanaka","year":"2022","unstructured":"Tanaka A, Nakano TA, Nomura M, Yamazaki H, Bewersdorf JP, Mulet-Lazaro R, et al. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia. Blood. 2022;140(8):875\u201388.","journal-title":"Blood"},{"issue":"8","key":"1331_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1182\/blood.2022017380","volume":"140","author":"EA Obeng","year":"2022","unstructured":"Obeng EA. Mutant SF3B1 splices a more leukemogenic EVI1. Blood. 2022;140(8):800\u20131.","journal-title":"Blood"},{"issue":"12","key":"1331_CR24","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1038\/s41375-022-01734-7","volume":"36","author":"S Huber","year":"2022","unstructured":"Huber S, Haferlach T, Meggendorfer M, Hutter S, Hoermann G, Baer C, et al. SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase. Leukemia. 2022;36(12):2927\u201330.","journal-title":"Leukemia"},{"issue":"8","key":"1331_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-018-0115-2","volume":"8","author":"YT Yang","year":"2018","unstructured":"Yang YT, Chiu YC, Kao CJ, Hou HA, Lin CC, Tsai CH, et al. The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome. Blood Cancer J. 2018;8(8):78.","journal-title":"Blood Cancer J"},{"issue":"10","key":"1331_CR26","doi-asserted-by":"publisher","first-page":"e0276674","DOI":"10.1371\/journal.pone.0276674","volume":"17","author":"M Szelest","year":"2022","unstructured":"Szelest M, Masternak M, Zaj\u0105c M, Chojnacki M, Sk\u00f3rka K, Zaleska J, et al. The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia. PLoS One. 2022;17(10):e0276674.","journal-title":"PLoS One"},{"issue":"9","key":"1331_CR27","first-page":"2690","volume":"10","author":"Z Dlamini","year":"2020","unstructured":"Dlamini Z, Shoba B, Hull R. Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkers. Am J Cancer Res. 2020;10(9):2690\u2013704.","journal-title":"Am J Cancer Res"},{"issue":"15","key":"1331_CR28","doi-asserted-by":"publisher","first-page":"e2014967118","DOI":"10.1073\/pnas.2014967118","volume":"118","author":"OD Rivera","year":"2021","unstructured":"Rivera OD, Mallory MJ, Quesnel-Valli\u00e8res M, Chatrikhi R, Schultz DC, Carroll M, et al. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia. Proc Natl Acad Sci. 2021;118(15):e2014967118.","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"1331_CR29","first-page":"11357","volume":"46","author":"KL Black","year":"2018","unstructured":"Black KL, Naqvi AS, Asnani M, Hayer KE, Yang SY, Gillespie E, et al. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Res. 2018;46(21):11357\u201369.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1331_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41375-022-01783-y","volume":"37","author":"S Huber","year":"2023","unstructured":"Huber S, Haferlach T, Meggendorfer M, Hutter S, Hoermann G, Summerer I, et al. Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. Leukemia. 2023;37(2):500\u20132.","journal-title":"Leukemia"},{"issue":"3","key":"1331_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.yexmp.2007.08.010","volume":"83","author":"RE Lewis","year":"2007","unstructured":"Lewis RE, Cruse JM, Sanders CM, Webb RN, Suggs JL. Aberrant expression of T-cell markers in acute myeloid leukemia. Exp Mol Pathol. 2007;83(3):462\u20133.","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"1331_CR32","first-page":"2870","volume":"7","author":"S Collins","year":"1987","unstructured":"Collins S, Coleman H, Groudine M. Expression of bcr and bcr-abl fusion transcripts in normal and leukemic cells. Mol Cell Biol. 1987;7(8):2870\u20136.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1331_CR33","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1182\/blood.V83.12.3689.3689","volume":"83","author":"R Rimokh","year":"1994","unstructured":"Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, et al. Rearrangement of CCND1 (BCL1\/PRAD1) 3\u2019 untranslated region in mantle- cell lymphomas and t(11q13)-associated leukemias. Blood. 1994;83(12):3689\u201396.","journal-title":"Blood"},{"issue":"19","key":"1331_CR34","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen A, Kilpinen S, Ruusulehto A, Lothe RA, Skotheim RI. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. 2016;35(19):2413\u201327.","journal-title":"Oncogene"},{"issue":"4","key":"1331_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1365-2141.1994.tb06747.x","volume":"87","author":"H Nakai","year":"1994","unstructured":"Nakai H, Kaneko H, Horiike S, Ariyama Y, Misawa S, Kashima K, et al. Multiple aberrant splicing of the p53 transcript without genomic mutations around exon-intron junctions in a case of chronic myelogenous leukaemia in blast crisis: a possible novel mechanism of p53 inactivation. Br J Haematol. 1994;87(4):839\u201342.","journal-title":"Br J Haematol"},{"key":"1331_CR36","first-page":"1","volume":"4","author":"N Wagner","year":"2023","unstructured":"Wagner N, \u00c7elik MH, H\u00f6lzlwimmer FR, Mertes C, Prokisch H, Y\u00e9pez VA, et al. Aberrant splicing prediction across human tissues. Nat Genet. 2023;55(5):861\u201370.","journal-title":"Nat Genet"},{"issue":"10","key":"1331_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Mui\u00f1os F, Sent\u00eds I, Deu-Pons J, Reyes-Salazar I, Arnedo-Pac C, et al. A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020;20(10):555\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1331_CR38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ajhg.2018.10.025","volume":"103","author":"F Brechtmann","year":"2018","unstructured":"Brechtmann F, Mertes C, Matusevi\u010di\u016bt\u0117 A, Y\u00e9pez VA, Avsec \u017d, Herzog M, et al. OUTRIDER: a statistical method for detecting aberrantly expressed genes in RNA sequencing data. Am J Hum Genet. 2018;103(6):907\u201317.","journal-title":"Am J Hum Genet"},{"key":"1331_CR39","doi-asserted-by":"crossref","unstructured":"Scheller IF, Lutz K, Mertes C, Y\u00e9pez VA, Gagneur J. Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index. Am J Hum Genet. 2023;110(12):2056\u201367.","DOI":"10.1016\/j.ajhg.2023.10.014"},{"issue":"10","key":"1331_CR40","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1182\/blood-2004-03-1036","volume":"104","author":"W Kern","year":"2004","unstructured":"Kern W, Voskova D, Schoch C, Hiddemann W, Schnittger S, Haferlach T. Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia. Blood. 2004;104(10):3078\u201385.","journal-title":"Blood"},{"issue":"2","key":"1331_CR41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2003.08.005","volume":"21","author":"T Haferlach","year":"2003","unstructured":"Haferlach T, Schoch C, L\u00f6ffler H, Gassmann W, Kern W, Schnittger S, et al. Morphologic Dysplasia in De Novo Acute Myeloid Leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group Studies. J Clin Oncol. 2003;21(2):256\u201365.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1331_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.leu.2402329","volume":"16","author":"C Schoch","year":"2002","unstructured":"Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A, Berger U, et al. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia. 2002;16(1):53\u20139.","journal-title":"Leukemia"},{"issue":"13","key":"1331_CR43","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1080\/10428194.2021.1953009","volume":"62","author":"C Haferlach","year":"2021","unstructured":"Haferlach C, Walter W, Stengel A, Meggendorfer M, Hutter S, Kern W, et al. The diverse landscape of fusion transcripts in 25 different hematological entities. Leuk Lymphoma. 2021;62(13):3292\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1331_CR44","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41375-020-1002-y","volume":"35","author":"CE Hershberger","year":"2021","unstructured":"Hershberger CE, Moyer DC, Adema V, Kerr CM, Walter W, Hutter S, et al. Complex landscape of alternative splicing in myeloid neoplasms. Leukemia. 2021;35(4):1108\u201320.","journal-title":"Leukemia"},{"issue":"21","key":"1331_CR45","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1182\/bloodadvances.2021004668","volume":"5","author":"A Stengel","year":"2021","unstructured":"Stengel A, Baer C, Walter W, Meggendorfer M, Kern W, Haferlach T, et al. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. Blood Adv. 2021;5(21):4426\u201334.","journal-title":"Blood Adv"},{"key":"1331_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cancergen.2020.01.001","volume":"242","author":"A H\u00f6llein","year":"2020","unstructured":"H\u00f6llein A, Twardziok SO, Walter W, Hutter S, Baer C, Hernandez-Sanchez JM, et al. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? Cancer Genet. 2020;242:15\u201324.","journal-title":"Cancer Genet"},{"issue":"D1","key":"1331_CR47","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish A, Diekhans M, Ferreira AM, Johnson R, Jungreis I, Loveland J, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47(D1):D766\u201373.","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"1331_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343.","journal-title":"Nature"},{"issue":"6","key":"1331_CR49","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gks1443","volume":"41","author":"M Costello","year":"2013","unstructured":"Costello M, Pugh TJ, Fennell TJ, Stewart C, Lichtenstein L, Meldrim JC, et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 2013;41(6):e67.","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"1331_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins RL, Brand H, Karczewski KJ, Zhao X, Alf\u00f6ldi J, Francioli LC, et al. A structural variation reference for medical and population genetics. Nature. 2020;581(7809):444\u201351.","journal-title":"Nature"},{"issue":"1","key":"1331_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"issue":"7457","key":"1331_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214\u20138.","journal-title":"Nature"},{"issue":"2","key":"1331_CR53","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41596-020-00462-5","volume":"16","author":"VA Y\u00e9pez","year":"2021","unstructured":"Y\u00e9pez VA, Mertes C, M\u00fcller MF, Klaproth-Andrade D, Wachutka L, Fr\u00e9sard L, et al. Detection of aberrant gene expression events in RNA sequencing data. Nat Protoc. 2021;16(2):1276\u201396.","journal-title":"Nat Protoc"},{"issue":"11","key":"1331_CR54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka Z, Bamford S, Cole CG, Ward SA, Dunham I, Forbes SA. The COSMIC cancer gene census: describing genetic dysfunction across all human cancers. Nat Rev Cancer. 2018;18(11):696\u2013705.","journal-title":"Nat Rev Cancer"},{"key":"1331_CR55","unstructured":"Auwera G., O'Connor B. Genomics in the Cloud. O'Reilly. 2020."},{"key":"1331_CR56","unstructured":"Therneau TM. A Package for Survival Analysis in R; 2023. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"1331_CR57","unstructured":"Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using \u201cggplot2\u201d. 2021. https:\/\/CRAN.Rproject.org\/package=survminer."},{"issue":"85","key":"1331_CR58","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12(85):2825\u201330.","journal-title":"J Mach Learn Res"},{"issue":"5","key":"1331_CR59","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41588-021-00840-z","volume":"53","author":"M Wainberg","year":"2021","unstructured":"Wainberg M, Kamber RA, Balsubramani A, Meyers RM, Sinnott-Armstrong N, Hornburg D, et al. A genome-wide atlas of co-essential modules assigns function to uncharacterized genes. Nat Genet. 2021;53(5):638\u201349.","journal-title":"Nat Genet"},{"issue":"4","key":"1331_CR60","doi-asserted-by":"publisher","first-page":"lqad095","DOI":"10.1093\/nargab\/lqad095","volume":"5","author":"F Brechtmann","year":"2023","unstructured":"Brechtmann F, Bechtler T, Londhe S, Mertes C, Gagneur J. Evaluation of input data modality choices on functional gene embeddings. NAR Genom Bioinform. 2023;5(4):lqad095.","journal-title":"NAR Genom Bioinform"},{"issue":"D1","key":"1331_CR61","doi-asserted-by":"publisher","first-page":"D1405","DOI":"10.1093\/nar\/gkac1033","volume":"51","author":"KJ Kelleher","year":"2023","unstructured":"Kelleher KJ, Sheils TK, Mathias SL, Yang JJ, Metzger VT, Siramshetty VB, et al. Pharos 2023: an integrated resource for the understudied human proteome. Nucleic Acids Res. 2023;51(D1):D1405\u201316.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1331_CR62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357\u201360.","journal-title":"Nat Methods"},{"issue":"12","key":"1331_CR63","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"1","key":"1331_CR64","doi-asserted-by":"publisher","first-page":"289","DOI":"10.32614\/RJ-2016-021","volume":"8","author":"L Scrucca","year":"2016","unstructured":"Scrucca L, Fop M, Murphy TB, Raftery AE. mclust 5: clustering, classification and density estimation using Gaussian finite mixture models. R J. 2016;8(1):289\u2013317.","journal-title":"R J"},{"issue":"22","key":"1331_CR65","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1093\/bioinformatics\/btz501","volume":"35","author":"C Arnedo-Pac","year":"2019","unstructured":"Arnedo-Pac C, Mularoni L, Mui\u00f1os F, Gonzalez-Perez A, Lopez-Bigas N. OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers. Bioinformatics. 2019;35(22):4788\u201390.","journal-title":"Bioinformatics"},{"issue":"1","key":"1331_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13059-016-0994-0","volume":"17","author":"L Mularoni","year":"2016","unstructured":"Mularoni L, Sabarinathan R, Deu-Pons J, Gonzalez-Perez A, L\u00f3pez-Bigas N. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biol. 2016;17(1):128.","journal-title":"Genome Biol"},{"issue":"13","key":"1331_CR67","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1158\/0008-5472.CAN-15-3190","volume":"76","author":"C Tokheim","year":"2016","unstructured":"Tokheim C, Bhattacharya R, Niknafs N, Gygax DM, Kim R, Ryan M, et al. Exome-scale discovery of hotspot mutation regions in human cancer using 3D protein structure. Cancer Res. 2016;76(13):3719\u201331.","journal-title":"Cancer Res"},{"issue":"1","key":"1331_CR68","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s43018-019-0001-2","volume":"1","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Mui\u00f1os F, L\u00f3pez-Arribillaga E, Lopez-Bigas N, Gonzalez-Perez A. Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer. Nat Cancer. 2020;1(1):122\u201335.","journal-title":"Nat Cancer"},{"issue":"12","key":"1331_CR69","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/ng.3987","volume":"49","author":"D Weghorn","year":"2017","unstructured":"Weghorn D, Sunyaev S. Bayesian inference of negative and positive selection in human cancers. Nat Genet. 2017;49(12):1785\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"1331_CR70","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41588-019-0572-y","volume":"52","author":"F Dietlein","year":"2020","unstructured":"Dietlein F, Weghorn D, Taylor-Weiner A, Richters A, Reardon B, Liu D, et al. Identification of cancer driver genes based on nucleotide context. Nat Genet. 2020;52(2):208\u201318.","journal-title":"Nat Genet"},{"issue":"5","key":"1331_CR71","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I, Raine KM, Gerstung M, Dawson KJ, Haase K, Van Loo P, et al. Universal patterns of selection in cancer and somatic tissues. Cell. 2017;171(5):1029-1041.e21.","journal-title":"Cell"},{"issue":"2","key":"1331_CR72","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ajhg.2022.12.015","volume":"110","author":"J Dekker","year":"2023","unstructured":"Dekker J, Schot R, Bongaerts M, de Valk WG, van Veghel-Plandsoen MM, Monfils K, et al. Web-accessible application for identifying pathogenic transcripts with RNA-seq: increased sensitivity in diagnosis of neurodevelopmental disorders. Am J Hum Genet. 2023;110(2):251\u201372.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1331_CR73","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41591-023-02401-9","volume":"29","author":"S Lunke","year":"2023","unstructured":"Lunke S, Bouffler SE, Patel CV, Sandaradura SA, Wilson M, Pinner J, et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat Med. 2023;29(7):1681\u201391.","journal-title":"Nat Med"},{"issue":"7","key":"1331_CR74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41525-022-00347-4","volume":"28","author":"M Lee","year":"2022","unstructured":"Lee M, Kwong AKY, Chui MMC, Chau JFT, Mak CCY, Au SLK, et al. Diagnostic potential of the amniotic fluid cells transcriptome in deciphering mendelian disease: a proof-of-concept. NPJ Genomic Med. 2022;28(7):74.","journal-title":"NPJ Genomic Med"},{"issue":"4","key":"1331_CR75","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41593-022-01031-7","volume":"25","author":"RA Vialle","year":"2022","unstructured":"Vialle RA, de Paiva LK, Bennett DA, Crary JF, Raj T. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain. Nat Neurosci. 2022;25(4):504\u201314.","journal-title":"Nat Neurosci"},{"issue":"4","key":"1331_CR76","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","volume":"155","author":"T Davoli","year":"2013","unstructured":"Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, Park PJ, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell. 2013;155(4):948\u201362.","journal-title":"Cell"},{"issue":"7832","key":"1331_CR77","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-020-2698-6","volume":"587","author":"TBK Watkins","year":"2020","unstructured":"Watkins TBK, Lim EL, Petkovic M, Elizalde S, Birkbak NJ, Wilson GA, et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature. 2020;587(7832):126\u201332.","journal-title":"Nature"},{"issue":"7675","key":"1331_CR78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature24267","volume":"550","author":"X Li","year":"2017","unstructured":"Li X, Kim Y, Tsang EK, Davis JR, Damani FN, Chiang C, et al. The impact of rare variation on gene expression across tissues. Nature. 2017;550(7675):239\u201343.","journal-title":"Nature"},{"issue":"1","key":"1331_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01391-5","volume":"3","author":"S Jiang","year":"2020","unstructured":"Jiang S. Tet2 at the interface between cancer and immunity. Commun Biol. 2020;3(1):667.","journal-title":"Commun Biol"},{"issue":"5","key":"1331_CR80","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/leu.2011.326","volume":"26","author":"S Weissmann","year":"2012","unstructured":"Weissmann S, Alpermann T, Grossmann V, Kowarsch A, Nadarajah N, Eder C, et al. Landscape of TET2 mutations in acute myeloid leukemia. Leukemia. 2012;26(5):934\u201342.","journal-title":"Leukemia"},{"key":"1331_CR81","doi-asserted-by":"crossref","unstructured":"Bensberg M, Rundquist O et al. TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci. 2021;118(34):e2110758118.","DOI":"10.1073\/pnas.2110758118"},{"key":"1331_CR82","doi-asserted-by":"crossref","unstructured":"Feng Y, Li X, Cassady K, Zou Z, Zhang X. TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair. Front Oncol. 2019;9:210.","DOI":"10.3389\/fonc.2019.00210"},{"issue":"5","key":"1331_CR83","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ccr.2012.10.017","volume":"22","author":"BB Zeisig","year":"2012","unstructured":"Zeisig BB, Kulasekararaj AG, Mufti GJ, Eric So CW. SnapShot: acute myeloid leukemia. Cancer Cell. 2012;22(5):698-698.e1.","journal-title":"Cancer Cell"},{"issue":"8","key":"1331_CR84","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/jcp.24329","volume":"228","author":"R Di Fiore","year":"2013","unstructured":"Di Fiore R, D\u2019Anneo A, Tesoriere G, Vento R. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis. J Cell Physiol. 2013;228(8):1676\u201387.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1331_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13073-022-01019-9","volume":"14","author":"VA Y\u00e9pez","year":"2022","unstructured":"Y\u00e9pez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, et al. Clinical implementation of RNA sequencing for Mendelian disease diagnostics. Genome Med. 2022;14(1):38.","journal-title":"Genome Med"},{"issue":"1","key":"1331_CR86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13059-019-1653-z","volume":"20","author":"J Cheng","year":"2019","unstructured":"Cheng J, Nguyen TYD, Cygan KJ, \u00c7elik MH, Fairbrother WG, Avsec \u017d, et al. MMSplice: modular modeling improves the predictions of genetic variant effects on splicing. Genome Biol. 2019;20(1):48.","journal-title":"Genome Biol"},{"issue":"3","key":"1331_CR87","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Panagiotopoulou SK, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535\u2013548.e24.","journal-title":"Cell"},{"issue":"7277","key":"1331_CR88","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 2010;463(7277):88\u201392.","journal-title":"Nature"},{"issue":"3","key":"1331_CR89","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3960\/jslrt.20010","volume":"60","author":"A Sakatani","year":"2020","unstructured":"Sakatani A, Igawa T, Okatani T, Fujihara M, Asaoku H, Sato Y, et al. Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma. J Clin Exp Hematop. 2020;60(3):78\u201386.","journal-title":"J Clin Exp Hematop"},{"issue":"1","key":"1331_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01591-z","volume":"4","author":"L Lenk","year":"2021","unstructured":"Lenk L, Carlet M, Vogiatzi F, Spory L, Winterberg D, Cousins A, et al. CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia. Commun Biol. 2021;4(1):1\u20136.","journal-title":"Commun Biol"},{"issue":"1","key":"1331_CR91","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"1331_CR92","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","volume":"125","author":"RC Lindsley","year":"2015","unstructured":"Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125(9):1367\u201376.","journal-title":"Blood"},{"issue":"15","key":"1331_CR93","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1182\/blood-2016-07-418434","volume":"128","author":"B Falini","year":"2016","unstructured":"Falini B, Martelli MP, Tiacci E. BRAF V600E mutation in hairy cell leukemia: from bench to bedside. Blood. 2016;128(15):1918\u201327.","journal-title":"Blood"},{"issue":"10","key":"1331_CR94","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3324\/haematol.2009.012047","volume":"94","author":"CG Mullighan","year":"2009","unstructured":"Mullighan CG. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia. Haematologica. 2009;94(10):1338\u201340.","journal-title":"Haematologica"},{"issue":"4","key":"1331_CR95","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ng.542","volume":"42","author":"P Van Vlierberghe","year":"2010","unstructured":"Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010;42(4):338\u201342.","journal-title":"Nat Genet"},{"issue":"19","key":"1331_CR96","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cca.2012.06.025","volume":"413","author":"S Sakai","year":"2012","unstructured":"Sakai S, Nakaseko C, Takeuchi M, Ohwada C, Shimizu N, Tsukamoto S, et al. Circulating soluble LR11\/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clin Chim Acta. 2012;413(19):1542\u20138.","journal-title":"Clin Chim Acta"},{"issue":"Supplement 1","key":"1331_CR97","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.1182\/blood-2022-170112","volume":"140","author":"PS Peramangalam","year":"2022","unstructured":"Peramangalam PS, Surapally S, Zheng S, Burns R, Zhu N, Rao S, et al. MYCN regulates cell survival via EIF4G1 in Inv(16) acute myeloid leukemia. Blood. 2022;140(Supplement 1):9117\u20138.","journal-title":"Blood"},{"issue":"11","key":"1331_CR98","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41419-021-04336-w","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Chen X, Huang Y, Lin J, Wu Y, Chen Y. TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT\/mTOR signaling. Cell Death Dis. 2021;12(11):1058.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1331_CR99","doi-asserted-by":"publisher","first-page":"e1003359","DOI":"10.1371\/journal.pgen.1003359","volume":"9","author":"JJ Kahle","year":"2013","unstructured":"Kahle JJ, Souroullas GP, Yu P, Zohren F, Lee Y, Shaw CA, et al. Ataxin1L Is a regulator of HSC function highlighting the utility of cross-tissue comparisons for gene discovery. PLoS Genet. 2013;9(3):e1003359.","journal-title":"PLOS Genet"},{"issue":"9","key":"1331_CR100","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129(9):1113\u201323.","journal-title":"Blood"},{"issue":"1","key":"1331_CR101","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2141.2008.07556.x","volume":"145","author":"I Riz","year":"2009","unstructured":"Riz I, Hawley TS, Johnston H, Hawley RG. Role of TLX1 in T-cell acute lymphoblastic leukemia pathogenesis. Br J Haematol. 2009;145(1):140\u20133.","journal-title":"Br J Haematol"},{"issue":"22","key":"1331_CR102","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1182\/blood.V128.22.2849.2849","volume":"128","author":"S Rudat","year":"2016","unstructured":"Rudat S, Pfaus A, B\u00fchler C, Rabe S, Bullinger L, Gr\u00f6schel S, et al. The RET receptor tyrosine kinase promotes acute myeloid leukemia through protection of FLT3-ITD mutants from autophagic degradation. Blood. 2016;128(22):2849.","journal-title":"Blood"},{"issue":"8","key":"1331_CR103","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41375-019-0402-3","volume":"33","author":"NA McNeer","year":"2019","unstructured":"McNeer NA, Philip J, Geiger H, Ries RE, Lavall\u00e9e VP, Walsh M, et al. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia. 2019;33(8):1934\u201343.","journal-title":"Leukemia"},{"issue":"1","key":"1331_CR104","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3892\/or.2021.8101","volume":"46","author":"JF Fu","year":"2021","unstructured":"Fu JF, Shih LY, Yen TH. HOXA11 plays critical roles in disease progression and response to cytarabine in AML. Oncol Rep. 2021;46(1):150.","journal-title":"Oncol Rep"},{"issue":"9","key":"1331_CR105","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ph14090836","volume":"14","author":"C Pr\u00edncipe","year":"2021","unstructured":"Pr\u00edncipe C, de Dion\u00edsioSousa IJ, Prazeres H, Soares P, Lima RT. LRP1B: a giant lost in cancer translation. Pharmaceuticals. 2021;14(9):836.","journal-title":"Pharmaceuticals"},{"issue":"10","key":"1331_CR106","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"2","key":"1331_CR107","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive characterization of cancer driver genes and mutations. Cell. 2018;173(2):371-385.e18.","journal-title":"Cell"},{"key":"1331_CR108","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Edition, Volume 2. IARC. 2017."},{"issue":"2","key":"1331_CR109","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1043-2760(01)00526-4","volume":"13","author":"DK Strickland","year":"2002","unstructured":"Strickland DK, Gonias SL, Argraves WS. Diverse roles for the LDL receptor family. Trends Endocrinol Metab. 2002;13(2):66\u201374.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1331_CR110","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/07853890701214881","volume":"39","author":"P May","year":"2007","unstructured":"May P, Woldt E, Matz RL, Boucher P. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med. 2007;39(3):219\u201328.","journal-title":"Ann Med"},{"issue":"11","key":"1331_CR111","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1515\/bc.2010.129","volume":"391","author":"M Dieckmann","year":"2010","unstructured":"Dieckmann M, Dietrich MF, Herz J. Lipoprotein receptors \u2013 an evolutionarily ancient multifunctional receptor family. Biol Chem. 2010;391(11):1341\u201363.","journal-title":"Biol Chem"},{"issue":"42","key":"1331_CR112","doi-asserted-by":"publisher","first-page":"68721","DOI":"10.18632\/oncotarget.11897","volume":"7","author":"AG Beer","year":"2016","unstructured":"Beer AG, Zenzmaier C, Schreinlechner M, Haas J, Dietrich MF, Herz J, et al. Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member. Oncotarget. 2016;7(42):68721\u201333.","journal-title":"Oncotarget"},{"issue":"2","key":"1331_CR113","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2011.02.030","volume":"216","author":"J Haas","year":"2011","unstructured":"Haas J, Beer AG, Widschwendter P, Oberdanner J, Salzmann K, Sarg B, et al. LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE \u2013 carrying lipoproteins. Atherosclerosis. 2011;216(2):342\u20137.","journal-title":"Atherosclerosis"},{"issue":"10","key":"1331_CR114","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1074\/jbc.M608088200","volume":"282","author":"CX Liu","year":"2007","unstructured":"Liu CX, Ranganathan S, Robinson S, Strickland DK. \u03b3-Secretase-mediated Release of the Low Density Lipoprotein Receptor-related Protein 1B Intracellular Domain Suppresses Anchorage-independent Growth of Neuroglioma Cells. J Biol Chem. 2007;282(10):7504\u201311.","journal-title":"J Biol Chem"},{"issue":"3","key":"1331_CR115","doi-asserted-by":"publisher","first-page":"e001792","DOI":"10.1136\/jitc-2020-001792","volume":"9","author":"LC Brown","year":"2021","unstructured":"Brown LC, Tucker MD, Sedhom R, Schwartz EB, Zhu J, Kao C, et al. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. J Immunother Cancer. 2021;9(3):e001792.","journal-title":"J Immunother Cancer"},{"issue":"16","key":"1331_CR116","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1158\/0008-5472.CAN-12-0203","volume":"72","author":"PA Cowin","year":"2012","unstructured":"Cowin PA, George J, Fereday S, Loehrer E, Van Loo P, Cullinane C, et al. LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. Cancer Res. 2012;72(16):4060\u201373.","journal-title":"Cancer Res"},{"issue":"13","key":"1331_CR117","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.7150\/jca.53124","volume":"12","author":"F Liu","year":"2021","unstructured":"Liu F, Hou W, Liang J, Zhu L, Luo C. LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma. J Cancer. 2021;12(13):4039\u201348.","journal-title":"J Cancer"},{"issue":"9","key":"1331_CR118","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ph14090836","volume":"14","author":"C Pr\u00edncipe","year":"2021","unstructured":"Pr\u00edncipe C, de Sousa IJD, Prazeres H, Soares P, Lima RT. LRP1B: a giant lost in cancer translation. Pharmaceuticals. 2021;14(9):836.","journal-title":"Pharmaceuticals"},{"issue":"15","key":"1331_CR119","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2019004226","volume":"136","author":"B Falini","year":"2020","unstructured":"Falini B, Brunetti L, Sportoletti P, Martelli MP. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood. 2020;136(15):1707\u201321.","journal-title":"Blood"},{"issue":"9","key":"1331_CR120","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3390\/cancers13092078","volume":"13","author":"M Ogawa","year":"2021","unstructured":"Ogawa M, Yokoyama K, Imoto S, Tojo A. Role of circulating tumor DNA in hematological malignancy. Cancers. 2021;13(9):2078.","journal-title":"Cancers"},{"key":"1331_CR121","doi-asserted-by":"publisher","first-page":"1164517","DOI":"10.3389\/fonc.2023.1164517","volume":"13","author":"D Talotta","year":"2023","unstructured":"Talotta D, Almasri M, Cosentino C, Gaidano G, Moia R. Liquid biopsy in hematological malignancies: current and future applications. Front Oncol. 2023;13:1164517.","journal-title":"Front Oncol"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-024-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-024-01331-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-024-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T12:04:31Z","timestamp":1716206671000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-024-01331-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1186\/s13073-024-01331-6","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients or their legal guardians gave written informed consent for genetic analyses and to the use of laboratory results and clinical data for research purposes, according to the Declaration of Helsinki. The consent can be found at: .The study was approved by the MLL\u2019s institutional review board and by the Bavarian Ethics Committee, the Bavarian State Medical Association (Bayerische Landes\u00e4rztekammer) with number 05117.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.H. declares part ownership of Munich Leukemia Laboratory (MLL). Sa.H. and St.H. are employed by the MLL. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}